nucleoside reverse transcriptase inhibitors

TERMINATED · PHASE4 · HIV Infections, HIV-Associated Lipodystrophy Syndrome

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.